Trastuzumab rezetecan, CAS 2924909-11-3

Product Description: Trastuzumab rezetecan (SHR-A1811) is a HER2-targeting antibody-drug conjugate (ADC). Trastuzumab rezetecan is composed of a humanized anti-HER2 antibody (HY-P9907), a cleavable linker MC-Gly-Gly-Phe-Gly (HY-44246), and a topoisomerase I inhibitor payload Rezetecán (HY-147408). Trastuzumab rezetecan can be used for research in HER2-positive breast cancer[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Khalil Saleh, et al. Mechanisms of action and resistance to anti-HER2 antibody-drug conjugates in breast cancer. Cancer Drug Resist. 2024 Jun 3:7:22.

CAS Number: 2924909-11-3

Molecular Weight: N/A

Compound Purity: 98.61

Research Area: Cancer

Target: Antibody-Drug Conjugates (ADCs);EGFR

• Artikelnummer: MEXHY-164762-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-164762-1
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK